Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
680 Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
